| __timestamp | Dr. Reddy's Laboratories Limited | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 2043000 |
| Thursday, January 1, 2015 | 62786000000 | 3895000 |
| Friday, January 1, 2016 | 62427000000 | 6552000 |
| Sunday, January 1, 2017 | 62453000000 | 15066000 |
| Monday, January 1, 2018 | 65724000000 | 26348000 |
| Tuesday, January 1, 2019 | 70421000000 | 33097000 |
| Wednesday, January 1, 2020 | 80591000000 | 36272000 |
| Friday, January 1, 2021 | 86645000000 | 52873000 |
| Saturday, January 1, 2022 | 100551000000 | 57909000 |
| Sunday, January 1, 2023 | 42907000000 | 72547000 |
| Monday, January 1, 2024 | 115557000000 | 0 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, Dr. Reddy's Laboratories Limited and Exelixis, Inc. present a fascinating study in contrasts. Over the past decade, Dr. Reddy's has consistently demonstrated a robust cost of revenue, peaking at approximately 115% of its 2014 value by 2024. This growth trajectory underscores its strategic investments and market expansion. In stark contrast, Exelixis, Inc. has shown a more modest increase, with its cost of revenue rising from a mere 2 million in 2014 to over 72 million by 2023, marking a significant 35-fold increase. However, the data for 2024 remains elusive, leaving room for speculation. This comparison not only highlights the differing scales and strategies of these two companies but also offers insights into their operational efficiencies and market positioning. As the pharmaceutical industry continues to innovate, these trends provide a window into the financial health and strategic priorities of key players.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Johnson & Johnson vs Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: GSK plc vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Biogen Inc. vs Dr. Reddy's Laboratories Limited: Efficiency in Cost of Revenue Explored
Insmed Incorporated vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Dyne Therapeutics, Inc.
Exelixis, Inc. vs Corcept Therapeutics Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
Analyzing Cost of Revenue: Exelixis, Inc. and Agios Pharmaceuticals, Inc.